Monoclonal Antibodies at Age 20: Promise at Last?
- 10 November 1995
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 270 (5238) , 915-916
- https://doi.org/10.1126/science.270.5238.915
Abstract
When they were first produced 2 decades ago, monoclonal antibodies were enthusiastically touted as “magic bullets” that would find wide application in medical therapeutics and diagnostics. But a variety of problems including severe immune reactions prevented them from living up to the early hype. A recent conference on monoclonals and cancer therapy suggests, however, that some of the difficulties are slowly being overcome.Keywords
This publication has 0 references indexed in Scilit: